Miragen Therapeutics Inc (NASDAQ:MGEN)

5.57
Delayed Data
As of 4:00pm ET
 +0.09 / +1.64%
Today’s Change
5.01
Today|||52-Week Range
18.00
-46.60%
Year-to-Date
No recent news for Miragen Therapeutics Inc.

Today’s Trading

Previous close5.48
Today’s open5.50
Day’s range5.36 - 5.60
Volume102,005
Average volume (3 months)218,485
Market cap$122.3M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+16.34%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratio37.0
Price/Sales1.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNOVMediciNova Inc+0.29+2.73%
CRHMCRH Medical Corp-0.17-5.83%
NYMXNymox Pharmaceutical...+0.05+1.58%
MACKMerrimack Pharmaceut...+0.08+0.71%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$3.3M
Annual profit (last year)-$12.7M
Net profit margin-379.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William S. Marshall
Chief Financial Officer, Secretary &
Treasurer
Jason A. Leverone
Corporate headquarters
Boulder, Colorado

Forecasts